Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Neurology Gastroenterology Rheumatology Diabetes / Metabolic Mental Health / Psychiatry Women's Health Dermatology Men's Health Rare Diseases
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

1020 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

1020 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Phase III Oncology
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated…
31 Mar 2026 NCT05894239
● Recruiting Phase I Neurology
A Study to Evaluate ALN-5288 in Patients With Alzheimer’s Disease
A Study to Evaluate ALN-5288 in Patients With Alzheimer’s Disease is Recruiting • Phase I • Neurology • NCT07214727. The purpose of this study…
31 Mar 2026 NCT07214727
● Recruiting Phase III Neurology
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer’s Disease (MINDSET 2)
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer’s Disease (MINDSET 2) is Recruiting • Phase…
31 Mar 2026 NCT06976203
● Recruiting Phase I Neurology
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOAD is Recruiting • Phase I • Neurology • NCT05231785. The…
31 Mar 2026 NCT05231785
● Recruiting Phase I Oncology
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal…
31 Mar 2026 NCT07293351
● Recruiting Phase III Diabetes / Metabolic
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD)
Implementation of Metformin theraPy to Ease Decline of Kidney Function in Polycystic Kidney Disease (IMPEDE-PKD) is Recruiting • Phase III • Diabetes / Metabolic…
31 Mar 2026 NCT04939935
● Recruiting
LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)
LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM) is Recruiting • Phase not applicable • NCT06446739. An estimated…
31 Mar 2026 NCT06446739
● Recruiting Phase III Infectious Disease
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide is Recruiting • Phase III • Infectious Disease…
31 Mar 2026 NCT07128550
● Recruiting Phase III Rheumatology
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn’s Disease
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn’s Disease is Recruiting • Phase III • Rheumatology • NCT05923073. The…
31 Mar 2026 NCT05923073
● Recruiting Phase III Oncology
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007) is Recruiting • Phase III • Oncology…
31 Mar 2026 NCT07190248
● Recruiting Phase III Oncology
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) is Recruiting…
31 Mar 2026 NCT06692738
● Recruiting Phase III Respiratory / COPD / Asthma
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) is Recruiting • Phase III • Respiratory /…
31 Mar 2026 NCT05943535
● Recruiting Phase III Oncology
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer…
31 Mar 2026 NCT06561386
● Recruiting Phase II Respiratory / COPD / Asthma
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma)
Rademikibart Add-on Treatment of an Acute Asthma Exacerbation (Seabreeze STAT Asthma) is Recruiting • Phase II • Respiratory / COPD / Asthma • NCT06940141.…
31 Mar 2026 NCT06940141
● Recruiting Phase II Respiratory / COPD / Asthma
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD)
Rademikibart Add-on Treatment of an Acute COPD Exacerbation (Seabreeze STAT COPD) is Recruiting • Phase II • Respiratory / COPD / Asthma • NCT06940154.…
31 Mar 2026 NCT06940154
● Recruiting Respiratory / COPD / Asthma
Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis
Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral Sclerosis is Recruiting • Phase not applicable • Respiratory /…
31 Mar 2026 NCT07502677
● Recruiting Cardiology / Cardiovascular
Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation
Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation is Recruiting • Phase not applicable • Cardiology…
31 Mar 2026 NCT07073781
● Recruiting Phase II Cardiology / Cardiovascular
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy
A Phase 2 Trial of ALN-APP in Patients With Cerebral Amyloid Angiopathy is Recruiting • Phase II • Cardiology / Cardiovascular • NCT06393712. The…
31 Mar 2026 NCT06393712
● Recruiting Phase III Cardiology / Cardiovascular
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy is Recruiting • Phase III • Cardiology / Cardiovascular • NCT07052903.…
31 Mar 2026 NCT07052903
● Recruiting Phase II Cardiology / Cardiovascular
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
Phase 2/3 Study of KPL-387 in Recurrent Pericarditis is Recruiting • Phase II • Cardiology / Cardiovascular • NCT07010159. This study is being done…
31 Mar 2026 NCT07010159
● Recruiting Cardiology / Cardiovascular
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT05701917. This…
31 Mar 2026 NCT05701917
● Recruiting Phase III Cardiology / Cardiovascular
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease is Recruiting • Phase…
31 Mar 2026 NCT07181109
● Recruiting Phase II Oncology
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations is Recruiting • Phase II • Oncology •…
31 Mar 2026 NCT06581432
● Recruiting Phase III Oncology
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator’s Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator’s Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients is Recruiting…
31 Mar 2026 NCT06496178
● Recruiting Phase I Oncology
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC) is Recruiting • Phase I • Oncology • NCT06217822.…
31 Mar 2026 NCT06217822
● Recruiting Phase II Oncology
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy is Recruiting • Phase…
31 Mar 2026 NCT07106762
● Recruiting Phase III Oncology
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer is Recruiting • Phase III…
31 Mar 2026 NCT06340568
● Recruiting Oncology
Targeted Pediatric High-Grade Glioma Therapy
Targeted Pediatric High-Grade Glioma Therapy is Recruiting • Phase not applicable • Oncology • NCT05839379. The goal of this study is to perform genetic…
31 Mar 2026 NCT05839379
● Recruiting Phase I Oncology
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion…
31 Mar 2026 NCT06360354
active not recruiting Phase II
Iptacopan in Patients With ANCA Associated Vasculitis
Iptacopan in Patients With ANCA Associated Vasculitis is Active Not Recruiting • Phase II • NCT06388941. Review the linked registry entry for study design,…
30 Mar 2026 NCT06388941
● Recruiting Diabetes / Metabolic
The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.
The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. is Recruiting • Phase not…
30 Mar 2026 NCT07499414
active not recruiting Phase III Diabetes / Metabolic
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight
A Research Study to See How Well Different Doses of CagriSema Help People With Excess Body Weight Lose Weight is Active Not Recruiting •…
30 Mar 2026 NCT06388187
● Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat…
30 Mar 2026 NCT06872905
● Recruiting Phase III Dermatology
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] is Recruiting…
30 Mar 2026 NCT05895786
active not recruiting Phase III
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
A Study Evaluating the Efficacy and Safety of Mitapivat in Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) is Active Not Recruiting •…
30 Mar 2026 NCT04770779
active not recruiting Phase II Oncology
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008)
Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC)…
30 Mar 2026 NCT04895722
● Recruiting Phase I
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas
A Trial to Study if REGN5837 in Combination With Odronextamab is Safe for Adult Participants With Aggressive B-cell Non-Hodgkin Lymphomas is Recruiting • Phase…
30 Mar 2026 NCT05685173
● Recruiting Phase II
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene
Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene is Recruiting • Phase…
30 Mar 2026 NCT06627179
● Recruiting Gastroenterology
Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).
Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC). is Recruiting • Phase not applicable • Gastroenterology • NCT07192393.…
30 Mar 2026 NCT07192393
active not recruiting Phase II
A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia
A Study to Determine the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of AG-348 in Adult Participants With Non-transfusion-dependent Thalassemia is Active Not Recruiting • Phase…
30 Mar 2026 NCT03692052
active not recruiting Respiratory / COPD / Asthma
Performance and Adherence in Children Using Spacers
Performance and Adherence in Children Using Spacers is Active Not Recruiting • Phase not applicable • Respiratory / COPD / Asthma • NCT05366309. Review…
30 Mar 2026 NCT05366309
● Recruiting Oncology
Imperial Prostate 9 – ATLAS (Approaches To Long-Term Active Surveillance)
Imperial Prostate 9 – ATLAS (Approaches To Long-Term Active Surveillance) is Recruiting • Phase not applicable • Oncology • NCT06280781. The goal of this…
30 Mar 2026 NCT06280781
● Recruiting Phase III Oncology
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants…
30 Mar 2026 NCT07028853
● Recruiting Oncology
Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery
Audit of Targeted Sentinel Node Biopsy (TSNB) in Patients With Limited Nodal Disease Undergoing Primary Surgery is Recruiting • Phase not applicable • Oncology…
30 Mar 2026 NCT07085442
● Recruiting Oncology
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy
Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy is Recruiting • Phase not applicable • Oncology •…
30 Mar 2026 NCT04109079
● Recruiting Phase III Neurology
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis. is Recruiting • Phase III • Neurology •…
30 Mar 2026 NCT06846281
● Recruiting Phase II
A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)
A Study to Evaluate Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN) is Recruiting • Phase II • NCT07204275.…
30 Mar 2026 NCT07204275
● Recruiting Phase II Gastroenterology
Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide
Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving Bulevirtide is Recruiting • Phase II • Gastroenterology…
30 Mar 2026 NCT07454837
● Recruiting Rheumatology
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis
A Study to Learn About the Effectiveness of Etrasimod in People With Ulcerative Colitis is Recruiting • Phase not applicable • Rheumatology • NCT06294925.…
30 Mar 2026 NCT06294925
● Recruiting Phase I Oncology
Study of XB010 in Subjects With Solid Tumors
Study of XB010 in Subjects With Solid Tumors is Recruiting • Phase I • Oncology • NCT06545331. This is a FIH study is to…
30 Mar 2026 NCT06545331